RTGN Stock Price, Chart, Stats & News

RetinalGenix Technologies Inc.
Save
RetinalGenix Technologies Inc. (RTGN) does not currently pay a dividend.
75.37M
Market cap
ā
Current P/E
ā
Forward P/E
RTGN chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Medical - Devices
Industry
RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients.
Similar securities
Based on sector and market capitalization
Report issue





